Shtesë kontrate: B4 - Blerje barna Antineoplastike dhe immunomodulatore për nevoja spitalore, e ndarë në Lote. Loti 9 - Barna Antineoplastike dhe immunomodulatore, ErLotinib, 150mg, Tabletë; Loti 13 - Barna Antineoplastike dhe immunomodulatore, Rituximab, 100mg/10ml, Flakon
|
Contracted Institution |
"Nënë Tereza" University Hospital Center |
|
Tenderer Institution |
"Nënë Tereza" University Hospital Center |
|
Tender object |
Shtesë kontrate: B4 - Blerje barna Antineoplastike dhe immunomodulatore për nevoja spitalore, e ndarë në Lote. Loti 9 - Barna Antineoplastike dhe immunomodulatore, ErLotinib, 150mg, Tabletë; Loti 13 - Barna Antineoplastike dhe immunomodulatore, Rituximab, 100mg/10ml, Flakon. Vlera totale përfundimtare e kontratës fillestare/Loti ishte 7 182 336 (me TVSH), lidhur me 27.05.2016 |
|
Reference No. |
|
|
Estimated / Ceiling Value ALL without VAT |
1 413 150,00 |
|
Type of Contract |
|
|
Procurement Method |
Additional Contracts
|
|
Stage Procedure |
Signed the Contract + Additional Contract |
|
Tender Publication Date |
|
|
Last date of Submitted Documents |
|
|
Tender Held Date |
16-01-2017 |
|
No. of Bidders |
|
|
Bidders |
IMI PHARMA SHPK |
|
Successful Bidder /Supplier / Provider |
IMI PHARMA SHPK |
|
The winning bid ALL without vat |
1 177 625,00 |
|
Bidder Announcement date |
|
|
Award and Contract Amount ALL with VAT |
1 413 150,00 |
|
Contract date |
16-01-2017 |
|
Planned Milestones of Contract / Start and End Date |
|
|
Renewal Contract Additional Value (ALL with VAT) |
|
|
Appeals |
|
|
Cancellation reason |
|
|
Additions |
|
|
Transaction / Actual Spending |
Monitor treasury transaction for IMI PHARMA SHPK viti 2012-2013 Monitor treasury transaction for IMI PHARMA SHPK viti 2014 Monitor treasury transaction for IMI PHARMA SHPK viti 2015-2018 Monitor treasury transaction for IMI PHARMA SHPK viti 2019-2020
|
|
Public Announcement Bulletin |
| Announcement of Procurement |
|
|
| Bidder Announcement |
|
| Signing of the Contract |
Nr.4 - Dt.30-01-2017 |
|
